Update on the role of antipsychotics in the treatment of Tourette syndrome

References

• MinkJWNeurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputsAdv Neurol200699899816536354
   PubMedGoogle Scholar
• JankovicJDifferential diagnosis and etiology of ticsAdv Neurol200185152911530424
   PubMedGoogle Scholar
• WongDFBrasićJRSingerHSMechanisms of dopaminergic and serotengeric neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PETNeuropsychopharmacology20083361239125117987065
   PubMed Web of Science ®Google Scholar
• WongDFSingerHSBrandtJD2-like dopamine receptor density in Tourette syndrome measured by PETJ Nucl Med1997388124312479255158
   PubMed Web of Science ®Google Scholar
• YoonDYGauseCDLeckmanJFSingerHSFrontal dopaminergic abnormality in Tourette syndrome: a postmortem analysisJ Neurol Sci20072551–2505617337006
   PubMed Web of Science ®Google Scholar
• YehCBLeeCHChouYHChangCJMaKHHuangWSEvaluating dopamine transporter activity with 99 mTc-TRODAT-1 SPECT in drug-naive Tourette’s adultsNucl Med Commun2006271077978416969259
   PubMed Web of Science ®Google Scholar
• YehCBLeeCSMaKHLeeMSChangCJHuangWSPhasic dysfunction of dopamine transmission in Tourette’s syndrome evaluated with (99 m)Tc TRODAT-1 imagingPsychiatry Res20071561758217716877
   PubMed Web of Science ®Google Scholar
• GilbertDTreatment of children and adolescents with tics and Tourette syndromeJ Child Neurol200621869070016970870
   PubMed Web of Science ®Google Scholar
• RoessnerVPlessenKJRothenbergerAEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentEur Child Adolesc Psychiatry201120417319621445724
   PubMed Web of Science ®Google Scholar
• ScahillLErenbergGBerlinCMJrContemporary assessment and pharmacotherapy of Tourette syndromeNeuro Rx20063219220616554257
   PubMedGoogle Scholar
• SingerHSTreatment of tics and tourette syndromeCurr Treat Options Neurol201012653956120848326
   PubMed Web of Science ®Google Scholar
• AzrinNHNunnRGHabit reversal: a method of eliminating nervous habits and ticsBehav Res Ther19731146196284777653
   PubMed Web of Science ®Google Scholar
• KuhnJGründlerTOLenartzDSturmVKlosterkötterJHuffWDeep brain stimulation for psychiatric disordersDtsch Arztebl Int2010107710511320221269
   PubMed Web of Science ®Google Scholar
• RickardsHHartleyNRobertsonMMSeignot’s paper on the treatment of Tourette’s syndrome with haloperidolHist Psychiatry1997831 Pt 343343611619589
   PubMed Web of Science ®Google Scholar
• ParragaHCHarrisKMParragaKLBalenGMCruzCAn overview of the treatment of Tourette’s disorder and ticsJ Child Adolesc Psychopharmacol201020424926220807063
   PubMed Web of Science ®Google Scholar
• ShapiroEShapiroAKFulopGControlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette’s syndromeArch Gen Psychiatry19894687227302665687
   PubMed Web of Science ®Google Scholar
• ShapiroAKShapiroESYoungJGFeinbergTEGilles de la Tourette Syndrome2nd edNew YorkRaven Press1988
   Google Scholar
• RossMSMoldofskyHA comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette’s syndromeAm J Psychiatry19781355585587347954
   PubMed Web of Science ®Google Scholar
• SalleeFRNesbittLJacksonCRelative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorderAm J Psychiatry19971548105710629247389
   PubMed Web of Science ®Google Scholar
• SandorPMusisiSMoldofskyHLangATourette syndrome: a follow-up studyJ Clin Psychopharmacol19901031971992115892
   PubMed Web of Science ®Google Scholar
• BorisonRLAngLHamiltonWJDiamondBIDavisJMTreatment approaches in Gilles de la Tourette syndromeBrain Res Bull19831122052086578865
   PubMed Web of Science ®Google Scholar
• EddyCMRickardsHECavannaAETreatment strategies for tics in Tourette syndromeTher Adv Neurol Disord201141254521339906
   PubMedGoogle Scholar
• GulisanoMCaliPVCavannaAEEddyCRickardsHRizzoRCardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndromeNeurol Sci20113261213121721732066
   PubMed Web of Science ®Google Scholar
• PringsheimTMarrasCPimozide for tics in Tourette’s syndromeCochrane Database Syst Rev20092CD00699619370666
   PubMed Web of Science ®Google Scholar
• BruggemanRvan der LindenCBuitelaarJKRisperidone versus pimozide in Tourette’s disorder: a comparative double-blind parallel-group studyJ Clin Psychiatry2001621505611235929
   PubMed Web of Science ®Google Scholar
• GilbertDLBattersonJRSethuramanGSalleeFRTic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trialJ Am Acad Child Adolesc Psychiatry200443220621414726728
   PubMed Web of Science ®Google Scholar
• SilayYSVuongKDJankovicJThe efficacy and safety of fluphenazine in patients with Tourette syndromeNeurology200462Suppl 5A506
   Google Scholar
• JankovicJJimenez-ShahedJBrownLWA randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndromeJ Neurol Neurosurg Psychiatry2009811707319726418
   PubMed Web of Science ®Google Scholar
• BorisonRLAngLChangSDyskenMComatyJEDavisJMNew pharmacological approaches in the treatment of Tourette syndromeAdv Neurol1982353773826756088
   PubMedGoogle Scholar
• GoetzCGTannerCMKlawansHLFluphenazine and multifocal tic disordersArch Neurol19844132712726582810
   PubMed Web of Science ®Google Scholar
• SingerHSGammonKQuaskeySHaloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatmentPediatr Neurosci1985–19862127174
   PubMedGoogle Scholar
• Müller-VahlKRThe benzamides tiapride, sulpiride, and amisulpride in treatment of Tourette’s syndromeNervenarzt200778326427116924461
   PubMed Web of Science ®Google Scholar
• DoseMLangeHWThe benzamine tiapride: treatment of extrapyramidal motor and other clinical syndromesPharmacopsychiatry2000331192710721880
   PubMed Web of Science ®Google Scholar
• MeiselAWinterCZschenderleinRArnoldGTourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiaprideMov Disord200419899199215300676
   PubMed Web of Science ®Google Scholar
• ScattonBCohenCPerraultGThe preclinical pharmacologic profile of tiaprideEur Psychiatry200116Suppl 129s34s11520476
   PubMed Web of Science ®Google Scholar
• BockNMollGHWickerMEarly administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic systemPharmacopsychiatry200437416316715467972
   PubMed Web of Science ®Google Scholar
• DrtilkovaIClonazepam, clonidine and tiapride in children with tic disorderHomeostasis1996375216
   Google Scholar
• KlepelHGebeltHKochRDTzenowHTreatment of extrapyramidal hyperkineses in childhood with tiapridePsychiatr Neurol Med Psychol (Leipz)19884095165223070595
   PubMedGoogle Scholar
• LipcseyAGilles de la Tourette’s diseaseSem Hop198359106956966304891
   PubMedGoogle Scholar
• EggersCRothenbergerABerghausUClinical and neurobiological findings in children suffering from tic disease following treatment with tiaprideEur Arch Psychiatry Neurol Sci198823742232292974416
   PubMedGoogle Scholar
• PaniLGessaGLThe substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaMol Psychiatry20027324725311920152
   PubMed Web of Science ®Google Scholar
• YvonneauMBezardPApropos of a case of Gilles de la Tourette’s disease blocked by sulpiride. Psycho-biological studyEncephale19705954394595278253
   PubMedGoogle Scholar
• RutherEDegnerDMunzelUAntidepressant action of sulpiride. Results of a placebo-controlled double-blind trialPharmacopsychiatry199932412713510505482
   PubMed Web of Science ®Google Scholar
• RobertsonMMSchneiderVLeesAJManagement of Gilles de la Tourette syndrome using sulpirideClin Neuropsychopharmacol1990133229235
   PubMed Web of Science ®Google Scholar
• HuangTLLuCYCorrelations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapyChang Gung Med J2007301263217477026
   PubMedGoogle Scholar
• WetterlingTMussigbrodtHEWeight gain: side effect of atypical neuroleptics?J Clin Psychopharmacol199919431632110440458
   PubMed Web of Science ®Google Scholar
• HoCSChenHJChiuNCShenEYLueHCShort-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorderJ Formos Med Assoc20091081078879319864199
   PubMed Web of Science ®Google Scholar
• GeorgeMSTrimbleMRRobertsonMMFluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and Gilles-De-La-Tourette syndromeHum Psychopharmacol Clin Exp19938327334
   Web of Science ®Google Scholar
• TrilletMMoreauTDaleryJde VillardRAimardGTreatment of Gilles de la Tourette’s disease with amisulpridePresse Med19901941751968252
   PubMed Web of Science ®Google Scholar
• FountoulakisKNIacovidesASt KaprinisGSuccessful treatment of Tourette’s disorder with amisulprideAnn Pharmacother200438590115010520
   PubMed Web of Science ®Google Scholar
• KozianRFriedrichMGilles-de-la-Tourette Syndrome as a Tardive DyskinesiaPsychiatr Prax200734525325417597439
   PubMed Web of Science ®Google Scholar
• CrillyJThe history of clozapine and its emergence in the US market: a review and analysisHist Psychiatry2007181396017580753
   PubMed Web of Science ®Google Scholar
• JaffeETremeauFSharifZReiderRClozapine in tardive Tourette syndromeBiol Psychiatry19953831961977578666
   PubMed Web of Science ®Google Scholar
• KalianMLernerVGoldmanMAtypical variants of tardive dyskinesia, treated by a combination of clozapine with propanolol and clozapine with tetrabenazineJ Nerv Ment Dis1993181106496518105027
   PubMed Web of Science ®Google Scholar
• CaineEDPolinskyRJKartzinelREbertMHThe trial use of clozapine for abnormal involuntary movement disordersAm J Psychiatry19791363317320154301
   PubMed Web of Science ®Google Scholar
• BegumMClozapine-induced stuttering, facial tics and myoclonic seizures: a case reportAust N Z J Psychiatry200539320215701074
   PubMed Web of Science ®Google Scholar
• BastiampillaiTDhillonRMohindraRExacerbation of tics secondary to clozapine therapyAust N Z J Psychiatry200842121068107019034993
   PubMed Web of Science ®Google Scholar
• KimBNLeeCBHwangJWShinMSChoSCEffectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in KoreaJ Child Adolesc Psychopharmacol200515231832415910216
   PubMed Web of Science ®Google Scholar
• van der LindenCBruggemanRvan WoerkomTCSerotonin-dopamine antagonist and Gilles de la Tourette’s syndrome: an open pilot dose-titration study with risperidoneMov Disord1994966876887531282
   PubMed Web of Science ®Google Scholar
• DiantoniisMRHenryKMPartridgePASoucarETics and risperidoneJ Am Acad Child Adolesc Psychiatry19963578398408768339
   PubMed Web of Science ®Google Scholar
• StamenkovicMAschauerHKasperSRisperidone for Tourette’s syndromeLancet19943448936157715787527115
   PubMed Web of Science ®Google Scholar
• ZhaoHZhuYRisperidone in the treatment of Tourette syndromeMent Health J20031730
   Google Scholar
• ScahillLLeckmanJFSchultzRTKatsovichLPetersonBSA placebo- controlled trial of risperidone in Tourette syndromeNeurology20036071130113512682319
   PubMed Web of Science ®Google Scholar
• DionYAnnableLSandorPChouinardGRisperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trialJ Clin Psychopharmacol2002221313911799340
   PubMed Web of Science ®Google Scholar
• LimLKShinSYRisperidone versus Haloperidol in the treatment of children with Tourette’s Syndrome and chronic motor or vocal tic disorder in KoreaEur Neuropsychopharacol2006165527
   Web of Science ®Google Scholar
• GaffneyGRPerryPJLundBCBever-StilleKAArndtSKupermanSRisperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndromeJ Am Acad Child Adolesc Psychiatry200241333033611886028
   PubMed Web of Science ®Google Scholar
• BruunRDBudmanCLRisperidone as a treatment for Tourette’s syndromeJ Clin Psychiatry199657129318543544
   PubMed Web of Science ®Google Scholar
• LombrosoPJScahillLKingRARisperidone treatment of children and adolescents with chronic tic disorders: a preliminary reportJ Am Acad Child Adolesc Psychiatry1995349114711527559308
   PubMed Web of Science ®Google Scholar
• ShulmanLMSingerCWeinerWJRisperidone in Gilles de la Tourette syndromeNeurology199545714197542376
   PubMed Web of Science ®Google Scholar
• RobertsonMMScullDAEapenVTrimbleMRRisperidone in the treatment of Tourette syndrome: a retrospective case note studyPsychopharmacol1996104317320
   Web of Science ®Google Scholar
• ChappellPBLeckmanJFRiddleMAThe pharmacological treatment of tic disordersChild Adolesc Psychiatric Clin North Am19954197216
   Google Scholar
• GiakasWJRisperidone treatment for a Tourette’s disorder patient with comorbid obsessive-compulsive disorderAm J Psychiatry19951527109710987540801
   PubMed Web of Science ®Google Scholar
• SandorPStephensRJRisperidone treatment of aggressive behavior in children with Tourette syndromeJ Clin Psychopharmacol200020671071211106151
   PubMed Web of Science ®Google Scholar
• PappadopulosEWoolstonSChaitAPerkinsMConnorDFJensenPSPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeJ Can Acad Child Adolesc Psychiatry2006151273918392193
   PubMedGoogle Scholar
• StephensRJBasselCSandorPOlanzapine in the treatment of aggression and tics in children with Tourette’s syndrome – a pilot studyJ Child Adolescent Psychopharmacol2004142255266
   PubMed Web of Science ®Google Scholar
• BudmanCLGayerALesserMShiQBruunRDAn open-label study of the treatment efficacy of olanzapine for Tourette’s disorderJ Clin Psychiatry200162429029411379844
   PubMed Web of Science ®Google Scholar
• McCrackenJTSuddathRChangSThakurSPiacentiniJEffectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndromeJ Child Adolesc Psychopharmacol200818550150818928414
   PubMed Web of Science ®Google Scholar
• http://www.lilly.comZyprexa product label Available from: http://pi.lilly.com/us/zyprexa-pi.pdfAccessed September 28, 2011
   Google Scholar
• JiWDLiYLiNGuoBYOlanzapine for treatment of Tourette syndrome: a double-blind randomized controlled trialChinese J Clin Rehab200596668
   Google Scholar
• OnofrjMPaciCD’AndreamatteoGTomaLOlanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs low-dose pimozideJ Neurol2000247644344610929273
   PubMed Web of Science ®Google Scholar
• Bengi SemerciZOlanzapine in Tourette’s disorderJ Am Acad Child Adolesc Psychiatry200039214010673820
   PubMed Web of Science ®Google Scholar
• BhadrinathBROlanzapine in Tourette syndromeBr J Psychiatry19981723669715346
   PubMed Web of Science ®Google Scholar
• Karam-HageMGhaziuddinNOlanzapine in Tourette’s disorderJ Am Acad Child Adolesc Psychiatry200039213910673819
   PubMed Web of Science ®Google Scholar
• Lucas TaracenaMTMontanes RadaFOlanzapine in Tourette’s syndrome: a report of three casesActas Esp Psiquiatr200230212913212028946
   PubMed Web of Science ®Google Scholar
• KrishnamoorthyJKingBHOpen-label olanzapine treatment in five preadolescent childrenJ Child Adolesc Psychopharmacol1998821071139730076
   PubMed Web of Science ®Google Scholar
• StamenkovicMSchindlerSDAschauerHNEffective open-label treatment of tourette’s disorder with olanzapineInt Clin Psychopharmacol2000151232810836282
   PubMed Web of Science ®Google Scholar
• ParragaHCParragaMIWoodwardRLFenningPAQuetiapine treatment of children with Tourette’s syndrome: report of two casesJ Child Adolesc Psychopharmacol200111218719111436959
   PubMed Web of Science ®Google Scholar
• MukaddesNMAbaliOQuetiapine treatment of children and adolescents with Tourette’s disorderJ Child Adolesc Psychopharmacol200313329529914642017
   PubMed Web of Science ®Google Scholar
• CopurMArpaciBDemirTNarinHClinical effectiveness of quetiapine in children and adolescents with Tourette’s syndrome: a retrospective case-note surveyClin Drug Investig2007272123130
   PubMed Web of Science ®Google Scholar
• KeckPEJrMcElroySLArnoldLMZiprasidone: a new atypical antipsychoticExpert Opin Pharmacother2001261033104211585006
   PubMedGoogle Scholar
• SalleeFRKurlanRGoetzCGZiprasidone treatment of children and adolescents with Tourette’s syndrome: a pilot studyJ Am Acad Child Adolesc Psychiatry200039329229910714048
   PubMed Web of Science ®Google Scholar
• StahlSMShayeganDKThe psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practiceJ Clin Psychiatry200364Suppl 19612
   Google Scholar
• SalleeFRMiceliJJTensfeldtTRobargeLWilnerKPatelNCSingle-dose pharmacokinetics and safety of ziprasidone in children and adolescentsJ Am Acad Child Adolesc Psychiatry45672072816721322
   PubMed Web of Science ®Google Scholar
• WillmundGLeeAHWertenauerFVocal tics associated with ziprasidoneJ Clin Psychopharmacol200929661161219910734
   PubMed Web of Science ®Google Scholar
• BudmanCCoffeyBJShechterRAripiprazole in children and adolescents with Tourette disorder with and without explosive outburstsJ Child Adolesc Psychopharmacol200818550951518928415
   PubMed Web of Science ®Google Scholar
• WoodMReavillCAripiprazole acts as a selective dopamine D2 receptor partial agonistExpert Opin Investig Drugs2007166771775
   PubMed Web of Science ®Google Scholar
• JordanSKoprivicaVChenRTottoriKKikuchiTAltarCAThe antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptorEur J Pharmacol2002441313714012063084
   PubMed Web of Science ®Google Scholar
• Ben DjebaraMWorbeYSchopbachMHartmannAAripiprazole: a treatment for severe coprolalia in “refractrory” Gilles de la Tourette syndromeMov Disord200815;233438440
   Web of Science ®Google Scholar
• BublEPerlovETebartzVanElstLAripiprazole in patients with Tourette syndromeWorld J Biol Psychiatry20067212312516684686
   PubMed Web of Science ®Google Scholar
• ConstantELBorrasLSeghersAAripiprazole is effective in the treatment of Tourette’s disorderInt J Neuropsychopharmacol20069677377416734937
   PubMed Web of Science ®Google Scholar
• CuiYHZhengYYangYPLiuJLiJEffectiveness and tolerability of aripiprazole in children and adolescents with Tourette’s disorder: a pilot study in ChinaJ Child Adolesc Psychopharmacol201020429129820807067
   PubMed Web of Science ®Google Scholar
• DaviesLSternJSAgrawalNRobertsonMMA case series of patients with Tourette’s syndrome in the United Kingdom treated with aripiprazoleHum Psychopharmacol200621744745317029306
   PubMed Web of Science ®Google Scholar
• DehningSRiedelMMullerNAripiprazole in a patient vulnerable to adverse reactionsAm J Psychiatry2005162362515741488
   PubMed Web of Science ®Google Scholar
• DuaneDDAripiprazole in childhood and adolescence for Tourette syndromeJ Child Neurol200621435816900939
   PubMed Web of Science ®Google Scholar
• FountoulakisKNSiamouliMKantartzisSPanagiotidisPIacovidesAKaprinisGSAcute dystonia with low-dosage aripiprazole in Tourette’s disorderAnn Pharmacother200640477577716569800
   PubMed Web of Science ®Google Scholar
• HoodKKLourivalBNBeasleyPJLobisRPravdovaICase study: severe self-injurious behavior in comorbid Tourette’s disorder and OCDJ Am Acad Child Adolesc Psychiatry2004431012961303
   Web of Science ®Google Scholar
• HounieADe MathisASampaioASMercadanteMTAripiprazole and Tourette syndromeRev Bras Psiquiatr200426321315645072
   PubMedGoogle Scholar
• Ikenouchi-SugitaAYoshimuraRHayashiKA case of late-onset Tourette’s disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)World J Biol Psychiatry2009104 Pt 397798019225990
   PubMed Web of Science ®Google Scholar
• KastrupASchlotterWPlewniaCBartelsMTreatment of tics in tourette syndrome with aripiprazoleJ Clin Psychopharmacol2005251949615643108
   PubMed Web of Science ®Google Scholar
• KawohlWSchneiderFVernalekenINeunerIAripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patientsWorld J Biol Psychiatry2009104 Pt 382783118843565
   PubMed Web of Science ®Google Scholar
• KawohlWSchneiderFVernalekenINeunerIChronic motor tic disorder and aripiprazoleJ Neuropsychiatry Clin Neurosci200921222419622695
   PubMed Web of Science ®Google Scholar
• LyonGJSamarSJummaniRAripiprazole in children and adolescents with Tourette’s disorder: an open-label safety and tolerability studyJ Child Adolesc Psychopharmacol200919662363320035580
   PubMed Web of Science ®Google Scholar
• MirandaCMCastiglioniTCAripiprazole for the treatment of Tourette syndrome. Experience in 10 patientsRev Med Chil2007135677377617728905
   PubMed Web of Science ®Google Scholar
• MurphyTKBengtsonMASotoOCase series on the use of aripiprazole for Tourette syndromeInt J Neuropsychopharmacol20058348949015857570
   PubMed Web of Science ®Google Scholar
• MurphyTKMutchPJReidJMOpen label aripiprazole in the treatment of youth with tic disordersJ Child Adolesc Psychopharmacol200919444144719702496
   PubMed Web of Science ®Google Scholar
• PadalaPRQadriSFMadaanVAripiprazole for the treatment of Tourette’s disorderPrim Care Companion J Clin Psychiatry20057629629916498492
   PubMedGoogle Scholar
• SeoWSSungHMSeaHSBaiDSAripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorderJ Child Adolesc Psychopharmacol200818219720518439116
   PubMed Web of Science ®Google Scholar
• WinterCHeinzAKupschAStrohleAAripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorderJ Clin Psychopharm2008284452454
   Web of Science ®Google Scholar
• YooHKChoiSHParkSWangHRHongJPKimCYAn open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disordersJ Clin Psychiatry20076871088109317685747
   PubMed Web of Science ®Google Scholar
• YooHKKimJYKimCYA pilot study of aripiprazole in children and adolescents with Tourette’s disorderJ Child Adolesc Psychopharmacol200616450550616958578
   PubMed Web of Science ®Google Scholar
• PaeCUA review of the safety and tolerability of aripiprazoleExpert Opin Drug Saf20098337338619505266
   PubMed Web of Science ®Google Scholar
• Müller-VahlKRRothenbergerARoessnerVPoeweWVingerhoetsFMünchauAGuidelines for diagnosis and treatment: Tic disordersDienerHCPutzkiNGuidelines for Diagnosis and Therapy in NeurologyStuttgart, Thieme2008125129 German
   Google Scholar
• RothenbergerABanaschewskiTRoessnerVTic disordersGerman Society for Child and Adolescent Psychiatry PuPGuidelines for Diagnosis and Treatment of Mental Disorders in Infancy, Childhood and AdolescenceKöln, Deutscher Ärzteverlag2007319325 German
   Google Scholar
• http://www.dgn.orgGuidelines of the German Society for Neurology Available from: http://www.dgn.org/images/stories/dgn/leitlinien/LL2008/ll08kap_012.pdfAccessed August 12, 2011 German
   Google Scholar
• ShahidMWalkerGBZornSHWongEHAsenapine: A novel psychopharmacologic agent with a unique human receptor signatureJ Psychopharmacol2009231657318308814
   PubMed Web of Science ®Google Scholar
• PompiliMVenturiniPInnamoratiMThe role of asenapine in the treatment of manic or mixed states associated with bipolar I disorderNeuropsychiatr Dis Treat2011725926521654871
   PubMed Web of Science ®Google Scholar
• AzorinJMKaladjianAFakraEAdidaMSertindole for the treatment of schizophreniaExpert Opin Pharmacother201011183053306421080854
   PubMed Web of Science ®Google Scholar
• FountoulakisKNSamaraMSiaperaMIacovidesATardive Tourette-like syndrome: a systematic reviewInt Clin Psychopharmacol201126523724221811171
   PubMed Web of Science ®Google Scholar
• JankovicJKurlanRTourette syndrome: evolving conceptsMov Disord20112661149115621484868
   PubMed Web of Science ®Google Scholar
• ScahillLChappellPBKimYSA placebo controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorderAm J Psychiatry200115871067107411431228
   PubMed Web of Science ®Google Scholar
• CummingsDDSingerHSKriegerMNeuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot studyClin Neuropharmacol200225632533212469007
   PubMed Web of Science ®Google Scholar